November 2022 Editor’s Choice: Management of primary low-grade serous ovarian carcinoma: are you up-to-date on the most contemporary prognostic factors and treatment strategies?
Listen to Gynecologic Oncology
English - November 03, 2022 05:15Science Health & Fitness medicine health care science and technology health national health service medical disease cancer politics diabetes Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Hosted by: Amanda Nickles Fader, MD, Associate Editor of Gynecologic Oncology
Featuring:
David M. Gershenson, MD, The University of Texas MD Anderson Cancer Center
Charlie Gourley, MD, Nicola Murray Centre for Ovarian Cancer Research
Editor’s Choice Paper: Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival
Editorial: Low grade serous ovarian cancer: Unpicking drivers of outcome